Therefore, this review discusses miRNAs, cytokines, and extracellular vesicles (as secretome) as well as transcription factors and immune checkpoints that influence the Treg/IL-17-producing Treg/Th17 cell axis in BC. This evidence concerns the gene IL17A and breast cancer.